SWOG clinical trial number
SWOG-8408
Evaluation of Esorubicin (4'Deoxydoxorubicin) in Advanced Endometrial Carcinoma
Closed
Phase
Published
Abbreviated Title
Evaluation of Esorubicin (4'Deoxydoxorubicin) in Advanced Endometrial Carcinoma
Activated
06/11/1984
Closed
05/01/1988
Publication Information Expand/Collapse
1991
Esorubicin in advanced endometrial cancer. An ineffective and potentially toxic therapy. A Southwest Oncology Group study.